About AnGes
About AnGes
Top Message
Values
Mission
Business Area
Business Model
Company Profile
Board of Directors
Locations
History
Group
Alliance Status
Pipeline
Pipeline
Main pipeline products
Product for HGF gene therapy
NF-κB Decoy Oligo DNA
Vaccine
Global Alliance
Global Alliance
EmendoBio, Inc.
MyBiotics Pharma Ltd.
ACRL
Investor Relations
Investor Relations
IR News
Stock Performance
Financial Reports
Intellectual Property Reports
Other Information Materials
Analyst Report
IR STREET(IR related information)
IR STREET(Email Alerts)
Corporate Brochure
Contact us
COVID-19
Contact us
Site Policy
Privacy Policy
JP
EN
Leading Global in Gene Medicine
About AnGes
News
All
Development
Product Info
IR
Information
2025.08.08
IR
Decision on the Development Policy for the HGF Gene Therapy Product in the United States and Regarding the Contract with Boehringer Ingelheim Biopharmaceuticals Notification Regarding the Drug Substance Supply Agreement
2025.08.08
IR
Consolidated Financial Report for the Second Quarter 2025
2025.05.26
Development
Notice on Publication on the Paper of Results of Late Phase I Clinical Trial of NF-κB Decoy Oligo DNA for the Treatment of Chronic Intervertebral Disc Lumbago in the US
2025.05.09
IR
Consolidated Financial Report for the First Quarter 2025
2025.05.07
Development
Vasomune Therapeutics Announces Poster Presentation at the American Thoracic Society International Conference
Learn more
Pipeline
Learn more
Global Alliance
Learn more
Contact us
